Beijing Shuimu Asset Management

The firm is closely affiliated with Tsinghua University, functioning as a venture capital arm that commercializes research originating within the university's technology ecosystem. This relationship provides a structural sourcing advantage: deal flow emerges from Tsinghua's labs, faculty spinouts, and alumni-founded startups in hard-tech verticals. The arrangement mirrors the endowment-linked venture models seen at Stanford and MIT, adapted to China's state-guided innovation funding environment.

Beijing Shuimu Asset Management focuses primarily on early-stage and expansion-stage venture capital. The firm invests from seed through Series B and later-stage pre-IPO rounds, with a concentration on companies that have recently commercialized technology developed within China's academic research infrastructure. Its stage coverage spans from proof-of-concept investments in university spinouts to growth equity in established deeptech firms.

The firm's strategy concentrates on hard technology, explicitly avoiding sectors that fall outside the deeptech and industrial innovation envelope. Consumer internet, platform-driven marketplaces, media, and non-tech sectors do not appear in its disclosed investment record. The focus remains tightly coupled to Tsinghua's core research strengths: AI, advanced manufacturing, robotics, and enterprise infrastructure software.

No. The firm does not publicly disclose its AUM. No regulatory filing, press report, or official communication confirms total capital raised or deployed. This opacity is characteristic of China-based university-affiliated managers that raise capital from institutional limited partners and government guidance funds, rather than marketing to foreign allocators.

Proprietary deal flow originates from Tsinghua University's research pipeline, including faculty-led commercialization projects, graduate-founded startups, and technology licensed through the university's technology transfer office. The network extends to state-sponsored innovation programs and China's broader academic-corporate research consortia, giving the firm access to deals that independent venture managers rarely see at formation stage.